Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-09-02 Sale | 2025-09-03 5:53 pm | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 5,501 | $19.87 | $109,325 | 18,469 (Direct) | View |
| 2025-08-29 Sale | 2025-09-03 5:51 pm | Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD Director | 61,885 | $20.13 | $1,245,698 | 91,585 (Direct) | View |
| 2025-08-29 Sale | 2025-09-03 5:50 pm | Stoke Therapeutics Inc. | STOK | Allan Jonathan GENERAL COUNSEL & CORP SEC | 22,117 | $20.11 | $444,809 | 52,583 (Direct) | View |
| 2025-08-18 Sale | 2025-08-20 4:13 pm | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 2,805 | $18.24 | $51,158 | 23,970 (Direct) | View |
| 2025-08-18 Sale | 2025-08-20 4:12 pm | Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD Director | 12,126 | $18.24 | $221,154 | 153,470 (Direct) | View |
| 2025-08-18 Sale | 2025-08-20 4:11 pm | Stoke Therapeutics Inc. | STOK | Allan Jonathan GENERAL COUNSEL & CORP SEC | 1,683 | $18.24 | $30,695 | 23,948 (Direct) | View |
| 2025-08-13 Sale | 2025-08-15 4:31 pm | Stoke Therapeutics Inc. | STOK | Allan Jonathan GENERAL COUNSEL & CORP SEC | 13,712 | $15 | $205,680 | 19,631 (Direct) | View |
| 2025-08-01 Sale | 2025-08-05 4:05 pm | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 4,504 | $12.82 | $57,724 | 16,775 (Direct) | View |
| 2025-07-01 Sale | 2025-07-02 4:09 pm | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 4,503 | $11.63 | $52,379 | 21,279 (Direct) | View |
| 2025-06-04 Sale | 2025-06-06 4:20 pm | Stoke Therapeutics Inc. | STOK | Skorpios Trust Blue Horizon Enterprise Ltd Ezbon International Ltd Montrago Trustees Ltd 10% Owner | 3,000,000 | $10.2 | $30,600,000 | 3,906,181 (Indirect) | View |
| 2025-06-02 Sale | 2025-06-04 8:30 pm | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 8,216 | $10.02 | $82,342 | 25,782 (Direct) | View |
| 2025-05-01 Sale | 2025-05-05 4:08 pm | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 26,631 | $10.02 | $266,953 | 33,998 (Direct) | View |
| 2025-03-18 Sale | 2025-03-20 6:15 pm | Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD Director | 19,289 | $8.4853 | $163,673 | 499,346 (Direct) | View |
| 2025-03-18 Sale | 2025-03-20 6:12 pm | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 7,217 | $8.4853 | $61,238 | 167,629 (Direct) | View |
| 2025-03-18 Sale | 2025-03-20 6:05 pm | Stoke Therapeutics Inc. | STOK | Allan Jonathan GENERAL COUNSEL & CORP SEC | 4,211 | $8.4852 | $35,731 | 151,565 (Direct) | View |
| 2024-12-23 Sale | 2024-12-27 5:13 pm | Stoke Therapeutics Inc. | STOK | Skorpios Trust Blue Horizon Enterprise Ltd Ezbon International Ltd Montrago Trustees Ltd 10% Owner | 2,000,000 | $11.5 | $23,000,000 | 6,906,181 (Indirect) | View |
| 2024-12-09 Sale | 2024-12-11 4:07 pm | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 2,586 | $12.99 | $33,596 | 44,746 (Direct) | View |
| 2024-12-09 Sale | 2024-12-11 4:05 pm | Stoke Therapeutics Inc. | STOK | Allan Jonathan GENERAL COUNSEL & CORP SEC | 13,666 | $13.61 | $185,978 | 21,476 (Direct) | View |
| 2024-12-09 Sale | 2024-12-11 4:04 pm | Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO | 6,786 | $12.99 | $88,158 | 61,885 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-08-29 Exercise | 2025-09-03 5:50 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Allan Jonathan GENERAL COUNSEL & CORP SEC | 10,000 | $7.07 | 52,583 (Direct) | View |
| 2025-08-29 Exercise | 2025-09-03 5:50 pm | N/A 2032-12-06 | Stoke Therapeutics Inc. | STOK | Allan Jonathan GENERAL COUNSEL & CORP SEC | 10,000 | $0 | 52,583 (Direct) | View |
| 2025-08-14 Option Award | 2025-08-18 8:25 pm | N/A 2026-08-14 | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 20,000 | $0 | 56,775 (Direct) | View |
| 2025-08-14 Exercise | 2025-08-18 8:25 pm | N/A 2026-08-14 | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 10,000 | $0 | 56,775 (Direct) | View |
| 2025-08-14 Option Award | 2025-08-18 8:24 pm | N/A 2026-08-14 | Stoke Therapeutics Inc. | STOK | Allan Jonathan GENERAL COUNSEL & CORP SEC | 12,000 | $0 | 43,631 (Direct) | View |
| 2025-08-14 Exercise | 2025-08-18 8:24 pm | N/A 2026-08-14 | Stoke Therapeutics Inc. | STOK | Allan Jonathan GENERAL COUNSEL & CORP SEC | 6,000 | $0 | 43,631 (Direct) | View |
| 2025-08-14 Option Award | 2025-08-18 8:23 pm | N/A 2026-08-14 | Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD Director | 52,500 | $0 | 244,346 (Direct) | View |
| 2025-08-14 Exercise | 2025-08-18 8:23 pm | N/A 2026-08-14 | Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD Director | 26,250 | $0 | 244,346 (Direct) | View |
| 2025-06-30 Exercise | 2025-07-02 4:08 pm | N/A 2025-12-31 | Stoke Therapeutics Inc. | STOK | LEVIN ARTHUR A Director | 1,210 | $0 | 22,821 (Direct) | View |
Ownership | 2025-06-23 4:16 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Hoitt Jason Chief Patient Officer | 0 | $0 | 521,802 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-04 8:38 pm | N/A 2035-06-02 | Stoke Therapeutics Inc. | STOK | Smith Julie Director | 29,747 | $0 | 29,747 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-04 8:36 pm | N/A 2035-06-02 | Stoke Therapeutics Inc. | STOK | LEVIN ARTHUR A Director | 29,747 | $0 | 29,747 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-04 8:35 pm | N/A 2035-06-02 | Stoke Therapeutics Inc. | STOK | Menzel Garry E Director | 29,747 | $0 | 29,747 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-04 8:34 pm | N/A 2035-06-02 | Stoke Therapeutics Inc. | STOK | Krainer Adrian R. Director | 29,747 | $0 | 29,747 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-04 8:33 pm | N/A 2035-06-02 | Stoke Therapeutics Inc. | STOK | Harrison Seth Loring Director | 29,747 | $0 | 29,747 (Direct) | View |
| 2025-06-03 Option Award | 2025-06-04 8:32 pm | N/A 2035-06-02 | Stoke Therapeutics Inc. | STOK | Burstein Jennifer Director | 29,747 | $0 | 29,747 (Direct) | View |
| 2025-03-31 Exercise | 2025-04-02 4:03 pm | N/A 2025-12-31 | Stoke Therapeutics Inc. | STOK | LEVIN ARTHUR A Director | 1,210 | $0 | 22,821 (Direct) | View |
| 2025-03-20 Option Award | 2025-03-20 6:19 pm | N/A 2035-03-19 | Stoke Therapeutics Inc. | STOK | SMITH IAN F Interim CEO | 238,420 | $0 | 238,420 (Direct) | View |
| 2025-03-20 Option Award | 2025-03-20 6:18 pm | N/A 2035-03-19 | Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Interim Executive Chair | 122,651 | $0 | 122,651 (Direct) | View |
| 2025-03-20 Option Award | 2025-03-20 6:17 pm | N/A 2035-03-19 | Stoke Therapeutics Inc. | STOK | Leggett Thomas Chief Financial Officer | 148,000 | $0 | 148,000 (Direct) | View |
| 2025-03-19 Option Award | 2025-03-20 6:16 pm | N/A 2025-12-31 | Stoke Therapeutics Inc. | STOK | LEVIN ARTHUR A Director | 4,842 | $0 | 4,842 (Direct) | View |
| 2025-03-20 Option Award | 2025-03-20 6:15 pm | N/A 2035-03-19 | Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD Director | 360,000 | $0 | 499,346 (Direct) | View |
| 2025-03-20 Option Award | 2025-03-20 6:12 pm | N/A 2035-03-19 | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 107,000 | $0 | 167,629 (Direct) | View |
| 2025-03-20 Option Award | 2025-03-20 6:05 pm | N/A 2035-03-19 | Stoke Therapeutics Inc. | STOK | Allan Jonathan GENERAL COUNSEL & CORP SEC | 120,000 | $0 | 151,565 (Direct) | View |
| 2025-03-15 Exercise | 2025-03-18 4:11 pm | N/A 2027-03-15 | Stoke Therapeutics Inc. | STOK | Allan Jonathan GENERAL COUNSEL & CORP SEC | 13,475 | $0 | 68,726 (Direct) | View |
| 2025-03-15 Exercise | 2025-03-18 4:08 pm | N/A 2027-03-15 | Stoke Therapeutics Inc. | STOK | Ticho Barry CHIEF MEDICAL OFFICER | 23,100 | $0 | 124,046 (Direct) | View |
| 2025-03-15 Exercise | 2025-03-18 4:07 pm | N/A 2027-03-15 | Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO | 61,750 | $0 | 308,385 (Direct) | View |
| 2024-12-30 Exercise | 2025-01-02 4:14 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO | 35,000 | $0.6 | 664,686 (Direct) | View |
| 2024-12-30 Exercise | 2025-01-02 4:14 pm | N/A 2028-04-02 | Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO | 35,000 | $0 | 664,686 (Direct) | View |